ADIPOQ and polycystic ovary syndrome: Unlike adiponectin, which has anti-inflammatory and insulin-sensitizing properties and is reduced in PCOS, VCAM-1 is elevated, reflecting an increased risk of vascular inflammation and cardiovascular events.